Stay updated on Sitravatinib for Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib for Metastatic Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T22:33:53.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website transition updates and says that both “Super Intelligence” and “Artificial Intelligence” may appear in NIH content during the transition.
    Difference
    1%
    Check dated 2026-10-24T22:26:55.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T22:27:17.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site footer now shows revision v3.7.1 instead of v3.7.0. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:21:10.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the expected study record for NCT04123704, indicating an access restriction. This blocks viewing the study details on ClinicalTrials.gov.
    Difference
    18%
    Check dated 2026-09-19T20:59:10.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6. This reflects a new version of the study record and associated documents, without altering the trial details.
    Difference
    0.1%
    Check dated 2026-08-29T20:08:35.000Z thumbnail image

Stay in the know with updates to Sitravatinib for Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.